Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study

BACKGROUND: We evaluated the burden of Shigella spp from children aged 0–59 months with medically attended moderate-to-severe diarrhea and matched controls at sites in Mali, The Gambia, and Kenya participating in the Vaccine Impact on Diarrhea in Africa (VIDA) study from 2015 to 2018. METHODS: Shige...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasumba, Irene N, Badji, Henry, Powell, Helen, Hossain, M Jahangir, Omore, Richard, Sow, Samba O, Verani, Jennifer R, Platts-Mills, James A, Widdowson, Marc-Alain, Zaman, Syed M A, Jones, Jennifer, Sen, Sunil, Permala-Booth, Jasnehta, Nasrin, Shamima, Roose, Anna, Nasrin, Dilruba, Ochieng, John Benjamin, Juma, Jane, Doh, Sanogo, Jones, Joquina Chiquita M, Antonio, Martin, Awuor, Alex O, Sugerman, Ciara E, Watson, Nora, Focht, Christopher, Liu, Jie, Houpt, Eric, Kotloff, Karen L, Tennant, Sharon M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
VIDA Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116563/
https://www.ncbi.nlm.nih.gov/pubmed/37074444
http://dx.doi.org/10.1093/cid/ciac969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116563/
https://www.ncbi.nlm.nih.gov/pubmed/37074444
http://dx.doi.org/10.1093/cid/ciac969

Ejemplares similares